Theriva Biologics Stock Forward View - Accumulation Distribution
| TOVX Stock | USD 0.19 0.03 13.64% |
Theriva Stock outlook is based on your current time horizon.
At this time the rsi of Theriva Biologics' share price is below 20 . This usually implies that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
EPS Estimate Next Quarter (0.37) | EPS Estimate Current Year (2.15) | EPS Estimate Next Year (0.75) | Wall Street Target Price 7 | EPS Estimate Current Quarter (0.38) |
Using Theriva Biologics hype-based prediction, you can estimate the value of Theriva Biologics from the perspective of Theriva Biologics response to recently generated media hype and the effects of current headlines on its competitors.
Theriva Biologics after-hype prediction price | USD 0.19 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Theriva Biologics to cross-verify your projections. Theriva Biologics Additional Predictive Modules
Most predictive techniques to examine Theriva price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Theriva using various technical indicators. When you analyze Theriva charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 94178.29 | 45275.0 |
| Check Theriva Biologics Volatility | Backtest Theriva Biologics | Information Ratio |
Theriva Biologics Trading Date Momentum
| On February 10 2026 Theriva Biologics was traded for 0.19 at the closing time. The top price for the day was 0.19 and the lowest listed price was 0.18 . The trading volume for the day was 860.2 K. The trading history from February 10, 2026 did not result in any price rise and fall. The trading price change against the current closing price is 0.00% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Theriva Biologics to competition |
Other Forecasting Options for Theriva Biologics
For every potential investor in Theriva, whether a beginner or expert, Theriva Biologics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Theriva Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Theriva. Basic forecasting techniques help filter out the noise by identifying Theriva Biologics' price trends.Theriva Biologics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Theriva Biologics stock to make a market-neutral strategy. Peer analysis of Theriva Biologics could also be used in its relative valuation, which is a method of valuing Theriva Biologics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Theriva Biologics Market Strength Events
Market strength indicators help investors to evaluate how Theriva Biologics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Theriva Biologics shares will generate the highest return on investment. By undertsting and applying Theriva Biologics stock market strength indicators, traders can identify Theriva Biologics entry and exit signals to maximize returns.
| Accumulation Distribution | 45275.0 | |||
| Daily Balance Of Power | (3.00) | |||
| Rate Of Daily Change | 0.86 | |||
| Day Median Price | 0.19 | |||
| Day Typical Price | 0.19 | |||
| Price Action Indicator | (0.01) | |||
| Period Momentum Indicator | (0.03) |
Theriva Biologics Risk Indicators
The analysis of Theriva Biologics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Theriva Biologics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting theriva stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 5.67 | |||
| Standard Deviation | 7.46 | |||
| Variance | 55.68 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Theriva Biologics
The number of cover stories for Theriva Biologics depends on current market conditions and Theriva Biologics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Theriva Biologics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Theriva Biologics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Theriva Biologics Short Properties
Theriva Biologics' future price predictability will typically decrease when Theriva Biologics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Theriva Biologics often depends not only on the future outlook of the potential Theriva Biologics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Theriva Biologics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1.3 M | |
| Cash And Short Term Investments | 11.6 M |
Additional Tools for Theriva Stock Analysis
When running Theriva Biologics' price analysis, check to measure Theriva Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theriva Biologics is operating at the current time. Most of Theriva Biologics' value examination focuses on studying past and present price action to predict the probability of Theriva Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theriva Biologics' price. Additionally, you may evaluate how the addition of Theriva Biologics to your portfolios can decrease your overall portfolio volatility.